Literature DB >> 8232301

Yeast protein splicing factors involved in nuclear pre-mRNA splicing.

J D Beggs1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232301     DOI: 10.1007/bf00986763

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


× No keyword cloud information.
  58 in total

1.  Requirement of the RNA helicase-like protein PRP22 for release of messenger RNA from spliceosomes.

Authors:  M Company; J Arenas; J Abelson
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

2.  The yeast RNA gene products are essential for mRNA splicing in vitro.

Authors:  A J Lustig; R J Lin; J Abelson
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

3.  PRP18, a protein required for the second reaction in pre-mRNA splicing.

Authors:  U Vijayraghavan; J Abelson
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

4.  Splicing of yeast nuclear pre-mRNA in vitro requires a functional 40S spliceosome and several extrinsic factors.

Authors:  R J Lin; A J Lustig; J Abelson
Journal:  Genes Dev       Date:  1987-03       Impact factor: 11.361

5.  A cold-sensitive mRNA splicing mutant is a member of the RNA helicase gene family.

Authors:  E J Strauss; C Guthrie
Journal:  Genes Dev       Date:  1991-04       Impact factor: 11.361

6.  PRP5: a helicase-like protein required for mRNA splicing in yeast.

Authors:  G Dalbadie-McFarland; J Abelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  PRP19: a novel spliceosomal component.

Authors:  S C Cheng; W Y Tarn; T Y Tsao; J Abelson
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

8.  Synthetic lethal mutations suggest interactions between U5 small nuclear RNA and four proteins required for the second step of splicing.

Authors:  D Frank; B Patterson; C Guthrie
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

9.  A trans-acting suppressor restores splicing of a yeast intron with a branch point mutation.

Authors:  J R Couto; J Tamm; R Parker; C Guthrie
Journal:  Genes Dev       Date:  1987-07       Impact factor: 11.361

10.  A conformational rearrangement in the spliceosome is dependent on PRP16 and ATP hydrolysis.

Authors:  B Schwer; C Guthrie
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  6 in total

1.  Functional and physical interactions between components of the Prp19p-associated complex.

Authors:  Chun-Hong Chen; Wan-Chin Yu; Twee Y Tsao; Lian-Yung Wang; Hau-Ren Chen; Jui-Yen Lin; Wei-Yü Tsai; Soo-Chen Cheng
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Spliceosome activation by PRP2 ATPase prior to the first transesterification reaction of pre-mRNA splicing.

Authors:  S H Kim; R J Lin
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

3.  Snt309p, a component of the Prp19p-associated complex that interacts with Prp19p and associates with the spliceosome simultaneously with or immediately after dissociation of U4 in the same manner as Prp19p.

Authors:  H R Chen; S P Jan; T Y Tsao; Y J Sheu; J Banroques; S C Cheng
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

4.  Snt309p modulates interactions of Prp19p with its associated components to stabilize the Prp19p-associated complex essential for pre-mRNA splicing.

Authors:  H R Chen; T Y Tsao; C H Chen; W Y Tsai; L S Her; M M Hsu; S C Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

5.  Interaction of the yeast splicing factor PRP8 with substrate RNA during both steps of splicing.

Authors:  S Teigelkamp; E Whittaker; J D Beggs
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

6.  In vitro reconstitution of mammalian U2 and U5 snRNPs active in splicing: Sm proteins are functionally interchangeable and are essential for the formation of functional U2 and U5 snRNPs.

Authors:  V Ségault; C L Will; B S Sproat; R Lührmann
Journal:  EMBO J       Date:  1995-08-15       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.